H1B Report
H-1B sponsorMIFEIN 20-5917382Updated Sep 2026

Kidney Disease and Hypertension Consultants

US H-1B Labor Condition Application activity for Kidney Disease and Hypertension Consultants. Filed 33 disclosures between FY2010 and FY2025 from worksites with a MI headquarters indicator.

Total filings
1
Outside top-N · FY2025
Certified
100.0%
unconditional · FY2025
Withdrawn
0.0%
withdrawn rate · FY2025
Denied
0.0%
rejection rate · FY2025

H-1B outcome breakdown

Share of Kidney Disease and Hypertension Consultants’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 78.8%, Cert-withdrawn 12.1%, Withdrawn 9.1%
Outcome breakdown
OutcomeShare
Certified78.8%
Cert-withdrawn12.1%
Withdrawn9.1%
Certified78.8%
Cert-withdrawn12.1%
Withdrawn9.1%

Top occupations sponsored

SOC codes filed most by Kidney Disease and Hypertension Consultants across all fiscal years. Click any row to open the national salary guide.

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY20102
FY20129
FY20142
FY20155
FY20179
FY20181
FY20192
FY20242
FY20251
Time series: 9 points from FY2010 to FY2025
Time series
PeriodValue
FY20102
FY20129
FY20142
FY20155
FY20179
FY20181
FY20192
FY20242
FY20251

This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.

Compare Kidney Disease and Hypertension Consultants with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.